진단 검사의학과와 중복되는 검사들의 결과 비교, 분석 (TSH, $FT_4$, AFP, CEA, PSA)

Comparison of Result Between NM and LM

  • 문기춘 (분당 서울대학교병원 핵의학과) ;
  • 권원현 (분당 서울대학교병원 핵의학과) ;
  • 김혜숙 (분당 서울대학교병원 핵의학과) ;
  • 이인원 (분당 서울대학교병원 핵의학과)
  • Moon, Ki-Choon (Department of Nuclear Medicine, Seoul National University Bundang Hospital) ;
  • Kwon, Won-Hyun (Department of Nuclear Medicine, Seoul National University Bundang Hospital) ;
  • Kim, Hye-Sook (Department of Nuclear Medicine, Seoul National University Bundang Hospital) ;
  • Lee, In-Won (Department of Nuclear Medicine, Seoul National University Bundang Hospital)
  • 투고 : 2009.08.15
  • 심사 : 2009.09.12
  • 발행 : 2009.10.10

초록

Purpose: Nowadays, NM (in vitro lab) and LM (TLA lab) are overlaped in almost all tests. in this case, how can NM develop continually in a keen competition with LM. we studied to find out current situation and problems after comparing NM with LM. Then, to improve our technic. Methods and meterials: We studied from October 2008 to February 2009 at department of nuclear medicine Seoul National University Bundang Hospital visited 108 patients. We assayed TSH, $FT_4$ by Ria-mat{TSH (n=23), $FT_4$ (n=19)} and AFP, CEA, PSA by manual. {AFP (n=24), CEA (n=31), PSA (n=31)}. On the other hand, LM was measured by TLA system. Results: NM was similar to LM (value of AFP), NMLM (value of PSA,TSH), NM$\leqq$LM (value of $FT_4$ in range 0.01~1.00 ng/mL), NM$\geqq$LM (value of $FT_4$ in range 1.00~6.00 ng/mL) Conclusions: There was no test which result showed big difference remarkably, but several tests have some difference totally or partly. It means that there is possibility to judge wrongly (normal patient->abnormal, abnormal->normal). So, we need to consider always when we report the result.

키워드